KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Current Deferred Revenue (2017 - 2026)

Cardlytics filings provide 10 years of Current Deferred Revenue readings, the most recent being $2.7 million for Q1 2026.

  • Quarterly Current Deferred Revenue rose 4.98% to $2.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Mar 2026, up 4.98% year-over-year, with the annual reading at $2.5 million for FY2025, 17.97% up from the prior year.
  • Current Deferred Revenue hit $2.7 million in Q1 2026 for Cardlytics, up from $2.5 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $4.7 million in Q2 2022 and bottomed at $1.5 million in Q1 2022.
  • Average Current Deferred Revenue over 5 years is $2.6 million, with a median of $2.6 million recorded in 2025.
  • Peak annual rise in Current Deferred Revenue hit 466.41% in 2022, while the deepest fall reached 46.62% in 2022.
  • Cardlytics' Current Deferred Revenue stood at $1.8 million in 2022, then skyrocketed by 37.35% to $2.4 million in 2023, then fell by 10.44% to $2.2 million in 2024, then rose by 17.97% to $2.5 million in 2025, then grew by 7.75% to $2.7 million in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Current Deferred Revenue are $2.7 million (Q1 2026), $2.5 million (Q4 2025), and $3.4 million (Q3 2025).